BG62793B1 - Антиестрогенни бензотиофенилни съединения - Google Patents

Антиестрогенни бензотиофенилни съединения Download PDF

Info

Publication number
BG62793B1
BG62793B1 BG101242A BG10124297A BG62793B1 BG 62793 B1 BG62793 B1 BG 62793B1 BG 101242 A BG101242 A BG 101242A BG 10124297 A BG10124297 A BG 10124297A BG 62793 B1 BG62793 B1 BG 62793B1
Authority
BG
Bulgaria
Prior art keywords
benzoyl
crystalline
benzo
reaction
hydroxy
Prior art date
Application number
BG101242A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101242A (en
Inventor
Elizabeth S. Labell
Wayne D. Luke
John M. Mcgill
Randal S. Miller
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26976194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG62793(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/308,325 external-priority patent/US5629425A/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG101242A publication Critical patent/BG101242A/xx
Publication of BG62793B1 publication Critical patent/BG62793B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
BG101242A 1994-09-19 1997-02-18 Антиестрогенни бензотиофенилни съединения BG62793B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/308,325 US5629425A (en) 1994-09-19 1994-09-19 Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
US42791495A 1995-04-26 1995-04-26
PCT/US1995/011872 WO1996009045A1 (en) 1994-09-19 1995-09-19 Antiestrogenic benzothiophenyl compounds

Publications (2)

Publication Number Publication Date
BG101242A BG101242A (en) 1998-03-31
BG62793B1 true BG62793B1 (bg) 2000-08-31

Family

ID=26976194

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101242A BG62793B1 (bg) 1994-09-19 1997-02-18 Антиестрогенни бензотиофенилни съединения

Country Status (51)

Country Link
US (4) US6399778B1 (fi)
JP (2) JPH08193081A (fi)
KR (2) KR100381346B1 (fi)
CN (2) CN1068324C (fi)
AP (1) AP754A (fi)
AT (2) AT502957A1 (fi)
AU (3) AU691955B2 (fi)
BE (2) BE1009626A3 (fi)
BG (1) BG62793B1 (fi)
BR (2) BR9504060A (fi)
CA (2) CA2158399C (fi)
CH (3) CH691125A5 (fi)
CO (2) CO4410190A1 (fi)
CZ (2) CZ290343B6 (fi)
DE (3) DE19534745B4 (fi)
DK (4) DK175903B1 (fi)
EE (1) EE03386B1 (fi)
EG (1) EG23763A (fi)
ES (2) ES2129293B1 (fi)
FI (2) FI121424B (fi)
FR (2) FR2732020B1 (fi)
GB (2) GB2293602B (fi)
GE (1) GEP19991821B (fi)
GR (2) GR1002709B (fi)
HK (1) HK1019009A1 (fi)
HR (2) HRP950482B1 (fi)
HU (2) HU227683B1 (fi)
IE (2) IE80883B1 (fi)
IL (3) IL115315A (fi)
IS (1) IS1788B (fi)
IT (2) IT1277602B1 (fi)
LU (2) LU88660A1 (fi)
LV (2) LV11178B (fi)
MY (1) MY116371A (fi)
NL (2) NL1001194C2 (fi)
NO (2) NO313996B1 (fi)
NZ (2) NZ280027A (fi)
OA (1) OA10406A (fi)
PE (2) PE32796A1 (fi)
PL (2) PL182450B1 (fi)
PT (2) PT101771B (fi)
RO (2) RO115260B1 (fi)
RS (2) RS49578B (fi)
SE (2) SE509265C2 (fi)
SI (2) SI9500292A (fi)
SK (1) SK283502B6 (fi)
TR (1) TR199501136A2 (fi)
TW (1) TW412534B (fi)
UA (2) UA44240C2 (fi)
UY (1) UY24040A1 (fi)
WO (1) WO1996009045A1 (fi)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
CO4410190A1 (es) * 1994-09-19 1997-01-09 Lilly Co Eli 3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
EP0910369B1 (en) * 1996-03-26 2010-04-21 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods
ZA979720B (en) 1996-10-30 1999-04-29 Lilly Co Eli Prophylaxis of breast cancer
CA2236254A1 (en) * 1997-04-30 1998-10-30 David Warren Hoard Process for preparing benzo¬b|thiophenes
ATE301129T1 (de) 1999-05-04 2005-08-15 Strakan Int Ltd Androgen glykoside und die androgenische aktivität davon
WO2002042289A2 (en) * 2000-11-27 2002-05-30 Eli Lilly And Company Process for preparing 3-aryl-benzo[b]thiophenes
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
CA2499819A1 (en) * 2002-09-30 2004-04-08 A/S Gea Farmaceutisk Fabrik Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004029784A1 (de) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004030502A1 (de) 2004-06-24 2006-01-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
DE102004033670A1 (de) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060074088A1 (en) 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US20060035903A1 (en) 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
EP1630163A1 (de) 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US8877933B2 (en) 2004-09-29 2014-11-04 Bayer Intellectual Property Gmbh Thermodynamically stable form of a tosylate salt
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102004058337A1 (de) 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
NO347644B1 (no) 2006-05-04 2024-02-12 Boehringer Ingelheim Int Polymorfer
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
AR062927A1 (es) 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
KR20090082399A (ko) * 2006-10-17 2009-07-30 씨아이피엘에이 엘티디. 벤조티오펜 화합물의 결정형 및 그의 제조방법
US20080103295A1 (en) * 2006-10-25 2008-05-01 David Losan Ho Process for the preparation of sucrose-6-ester by esterification in the presence of solid superacid catalyst
US8258291B2 (en) * 2006-10-25 2012-09-04 Mamtek International Limited Process for the preparation of sucralose by the chlorination of sugar with triphosgene (BTC)
DE102007032451B4 (de) 2007-07-12 2010-09-30 Icfs Gmbh Verfahren zur Herstellung von aromatischen Ketonen
US20090023799A1 (en) * 2007-07-20 2009-01-22 George Laurence CRYSTALS OF (2-AMINO-4,5,6,7-TETRAHYDROBENZO[b]THIEN-3-YL)(4-CHLOROPHENYL)METHANONE
WO2009019205A1 (en) 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
CL2008003799A1 (es) * 2007-12-21 2009-12-18 Synthon Bv Composicion farmaceutica que comprende raloxifeno en forma de tableta de liberacion inmediata; util para el tratamiento y/o prevencion de la osteoporosis.
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
US20110088613A1 (en) * 2008-06-09 2011-04-21 Massimo Ferrari Process for controlling the growth of a raloxifene hydrochloride crystal
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
AU2009290911A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CA2745037C (en) 2008-12-23 2020-06-23 Boehringer Ingelheim International Gmbh Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8(3-(r)-amino-piperidin-1-yl)-xanthine
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
WO2011000581A2 (en) 2009-07-02 2011-01-06 Synthon B.V. Raloxifene composition
EP2314581B1 (en) 2009-10-23 2012-07-25 Hexal AG A process for preparing benzo[b]thiophene derivatives
MX364651B (es) 2009-11-27 2019-05-03 Boehringer Ingelheim Int Gmbh Star Inhibidores de dpp-iv, tales como la linagliptina, y composiciones farmacéuticas o combinaciones que comprenden los mismos, para usarse en el tratamiento de pacientes diabéticos tipificados genéticamente.
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
MX2012014247A (es) 2010-06-24 2013-01-18 Boehringer Ingelheim Int Terapia para la diabetes.
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
IT1403083B1 (it) * 2010-10-25 2013-10-04 Fidia Farmaceutici Nuova forma polimorfa di raloxifene cloridrato
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
EA030121B1 (ru) 2011-07-15 2018-06-29 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные хиназолины, их получение и их применение в фармацевтических композициях
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
JP6224084B2 (ja) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
IN2013MU00665A (fi) 2013-03-05 2015-07-03 Cipla Ltd
JP2016525532A (ja) 2013-07-26 2016-08-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 骨髄異形成症候群の処置
WO2015128453A1 (en) 2014-02-28 2015-09-03 Boehringer Ingelheim International Gmbh Medical use of a dpp-4 inhibitor
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
CN104496963A (zh) * 2014-12-02 2015-04-08 千辉药业（安徽）有限责任公司 一种盐酸雷洛昔芬的制备方法
EP4233840A3 (en) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869485A (en) * 1969-09-25 1975-03-04 Allied Chem Preparation of acid chlorides with phosgene in the presence of a catalyst
GB1456323A (en) * 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
ZA822247B (en) 1981-04-03 1983-11-30 Lilly Co Eli Benzothiophene compounds and process for preparing them
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
PH18628A (en) * 1981-04-03 1985-08-23 Lilly Co Eli "6-hydroxy-2-(4-hydroxyphenyl)-3 4-(2- piperidine or 3-methylpyrollidine -benzo b thiophene compounds
IL65378A (en) 1981-04-03 1986-02-28 Lilly Co Eli Process for preparing 3-(4-aminoethoxybenzoyl)benzo-(b)thiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4358593A (en) 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
IL65379A0 (en) * 1981-04-03 1982-05-31 Lilly Co Eli Process for preparing acylated benzothiophenes
DE4117512A1 (de) * 1991-05-25 1992-11-26 Schering Ag 2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5169860A (en) 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
EP0635264B1 (en) 1993-06-24 1997-09-10 Eli Lilly And Company Antiestrogenic 2-phenyl-3-aroylbenzothiophenes as hypoglycemic agents
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5523416A (en) 1994-07-22 1996-06-04 Eli Lilly And Company Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
CO4410190A1 (es) * 1994-09-19 1997-01-09 Lilly Co Eli 3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO

Also Published As

Publication number Publication date
AU692907B2 (en) 1998-06-18
GR1002709B (el) 1997-06-04
IL115315A (en) 1999-09-22
GB2293602B (en) 1998-05-06
HU9502721D0 (en) 1995-11-28
HU9502723D0 (en) 1995-11-28
KR960010634A (ko) 1996-04-20
LV11177B (en) 1996-08-20
SE9503213L (sv) 1996-03-20
FR2732020B1 (fr) 1997-11-14
IL115314A (en) 2000-02-29
HUT74178A (en) 1996-11-28
NL1001196A1 (nl) 1996-03-19
NO953658L (no) 1996-03-20
CZ240395A3 (en) 1996-04-17
GB2293382A (en) 1996-03-27
UA42716C2 (uk) 2001-11-15
YU61495A (sh) 1998-05-15
RO115260B1 (ro) 1999-12-30
CN1132205A (zh) 1996-10-02
FI112226B (fi) 2003-11-14
UA44240C2 (uk) 2002-02-15
HRP950483B1 (en) 2003-02-28
FI954402A0 (fi) 1995-09-18
ES2109882B1 (es) 1998-08-16
FI954402A (fi) 1996-03-20
NO953658D0 (no) 1995-09-15
PL310517A1 (en) 1996-04-01
AP9700938A0 (en) 1997-04-30
IE80883B1 (en) 1999-05-19
FR2724655A1 (fr) 1996-03-22
SE9503213D0 (sv) 1995-09-15
GB2293382B (en) 1998-08-19
TR199501136A2 (tr) 1996-06-21
RO115259B1 (ro) 1999-12-30
NL1001194A1 (nl) 1996-03-19
CA2158399A1 (en) 1996-03-20
LU88661A1 (fr) 1996-07-15
CA2158400C (en) 2006-10-24
PL182450B1 (pl) 2002-01-31
IE950721A1 (en) 1996-03-20
HRP950482B1 (en) 2007-04-30
DK102895A (da) 1996-03-20
DK175903B1 (da) 2005-06-06
HRP950483A2 (en) 1997-10-31
HUT75033A (en) 1997-03-28
CH691478A5 (de) 2001-07-31
BE1009626A3 (fr) 1997-06-03
LV11178A (lv) 1996-04-20
SE9503214L (sv) 1996-03-20
CZ240295A3 (en) 1996-04-17
GR1002697B (el) 1997-05-22
NL1001194C2 (nl) 1997-04-04
IT1277602B1 (it) 1997-11-11
DK175897B1 (da) 2005-05-30
EG23763A (en) 2007-08-08
IS1788B (is) 2001-11-28
FR2732020A1 (fr) 1996-09-27
HU227683B1 (en) 2011-11-28
MY116371A (en) 2004-01-31
DK2797A (da) 1997-01-09
CZ292007B6 (cs) 2003-07-16
SE9503214D0 (sv) 1995-09-15
CZ290343B6 (cs) 2002-07-17
IL125283A (en) 2001-06-14
DE19534744A1 (de) 1996-03-21
JP2860071B2 (ja) 1999-02-24
NO313996B1 (no) 2003-01-13
BE1009625A3 (fr) 1997-06-03
LU88660A1 (fr) 1996-07-15
SK23397A3 (en) 1997-08-06
NO953657L (no) 1996-03-20
AU3173095A (en) 1996-04-04
DE19534745B4 (de) 2004-06-09
BG101242A (en) 1998-03-31
PE32796A1 (es) 1996-08-07
PT101771B (pt) 1997-04-30
PT101770B (pt) 1997-04-30
PT101770A (pt) 1996-04-30
CN1068324C (zh) 2001-07-11
DK2897A (da) 1997-01-09
DK102795A (da) 1996-03-20
PL310518A1 (en) 1996-04-01
AU3718695A (en) 1996-04-09
CA2158399C (en) 2001-03-20
SI9500292A (en) 1996-06-30
JPH08176147A (ja) 1996-07-09
DE19549755B4 (de) 2005-05-04
HK1019009A1 (en) 2000-01-14
UY24040A1 (es) 1996-03-07
RS49578B (sr) 2007-04-10
ES2129293B1 (es) 2000-01-16
DK175887B1 (da) 2005-05-23
BR9504060A (pt) 1996-09-24
YU61395A (sh) 1998-09-18
US6399778B1 (en) 2002-06-04
ATA154295A (de) 2000-12-15
IL115315A0 (en) 1995-12-31
SE509265C2 (sv) 1998-12-21
FI121424B (fi) 2010-11-15
AU3173195A (en) 1996-04-04
SK283502B6 (sk) 2003-08-05
FR2724655B1 (fr) 1997-11-14
ITMI951936A1 (it) 1997-03-15
AT502957A1 (de) 2007-06-15
KR100367376B1 (ko) 2003-03-06
FI954403A (fi) 1996-03-20
DE19534745A1 (de) 1996-04-04
SE520721C2 (sv) 2003-08-12
KR100381346B1 (ko) 2004-04-13
IT1277601B1 (it) 1997-11-11
CA2158400A1 (en) 1996-03-20
IL115314A0 (en) 1996-05-14
US6472531B1 (en) 2002-10-29
CH691125A5 (de) 2001-04-30
HU225417B1 (en) 2006-11-28
US5731327A (en) 1998-03-24
LV11178B (en) 1996-08-20
FI954403A0 (fi) 1995-09-18
ITMI951936A0 (it) 1995-09-15
BR9504059A (pt) 1996-09-24
CN1127253A (zh) 1996-07-24
DK175886B1 (da) 2005-05-23
CH691594A5 (de) 2001-08-31
HRP950482A2 (en) 1998-02-28
IE950722A1 (en) 1996-03-20
SI9500293A (en) 1996-06-30
WO1996009045A1 (en) 1996-03-28
IS4446A (is) 1997-03-18
GB9519032D0 (en) 1995-11-15
ES2129293A1 (es) 1999-06-01
JPH08193081A (ja) 1996-07-30
AT407988B (de) 2001-07-25
LV11177A (lv) 1996-04-20
NZ280028A (en) 1997-05-26
GB9519028D0 (en) 1995-11-15
AP754A (en) 1999-07-22
CO4410190A1 (es) 1997-01-09
ES2109882A1 (es) 1998-01-16
NO953657D0 (no) 1995-09-15
NL1001196C2 (nl) 1997-04-04
NZ280027A (en) 1997-05-26
ITMI951935A0 (it) 1995-09-15
AU691955B2 (en) 1998-05-28
PE14796A1 (es) 1996-05-19
OA10406A (en) 2001-12-05
EE9700055A (et) 1997-08-15
TW412534B (en) 2000-11-21
EE03386B1 (et) 2001-04-16
ITMI951935A1 (it) 1997-03-15
CO4410191A1 (es) 1997-01-09
GB2293602A (en) 1996-04-03
PT101771A (pt) 1996-04-30
NO308107B1 (no) 2000-07-24
US20020173645A1 (en) 2002-11-21
CN1075069C (zh) 2001-11-21
RS49513B (sr) 2006-10-27
KR960010637A (ko) 1996-04-20
GEP19991821B (en) 1999-11-05
PL187686B1 (pl) 2004-09-30

Similar Documents

Publication Publication Date Title
BG62793B1 (bg) Антиестрогенни бензотиофенилни съединения
RU2108331C1 (ru) Способ получения кристаллического сольвата, кристаллический сольват 6-гидрокси-2-(4-гидроксифенил)-3-[4-(2-пиперидиноэтокси)бензоил]бензо(b)тиофенгидрохлорида и способ получения несольватированного кристаллического 6-гидрокси-2-(4-гидроксифенил)-3-[4-(2-пиперидиноэтокси)бензоил]бензо(b)тиофенгидрохлорида
WO1997034888A1 (en) SYNTHESIS OF 3-[4-(2-AMINOETHOXY)-BENZOYL]-2-ARYL-6-HYDROXY-BENZO[b]THIOPHENES